William Sansum Diabetes Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Santa Barbara CA United States (1944)

Organization Overview

First Clinical Trial
2008
NCT01613807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

insulin human (humulin) (3 trials)

insulin lispro (humalog) (2 trials)

Drugs in Phase 2 Trials (1)

insulin glulisine (Apidra) (1 trial)

Drugs in Phase 1 Trials (4)

esomeprazole (nexium) (1 trial)

estradiol (progynon depot) (1 trial)

somatropin (protropin) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7